Pancreatic Cancer Research

ResearcherUniversity Hospital MünsterActive in the last 2 years

Soeren Torge Mees

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3876-3535; OpenAlex author ID A5086965439, A5110559661. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 8

  1. Perioperative outcomes in an age-adapted analysis of the German StuDoQ|Pancreas registry for PDAC. Co-author DOI 10.1186/s12893-024-02647-1↗
  2. A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patients. Co-author DOI 10.1007/s00423-024-03570-y↗
  3. SERPINB5 Promoter Hypomethylation Differentiates Pancreatic Ductal Adenocarcinoma From Pancreatitis. Co-author DOI 10.1097/mpa.0000000000000526↗
  4. MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer. Co-author DOI 10.1038/bjc.2014.587↗
  5. MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1371/journal.pone.0143755↗
  6. Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/1471-2407-13-264↗
  7. Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer--a review. Co-author DOI 10.1002/ijc.26078↗
  8. Role of tumor microenvironment on gene expression in pancreatic cancer tumor models. Co-author DOI 10.1016/j.jss.2010.03.034↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tobias Keck · 2 shared papers, 2024–2025 · strength 0.36
  2. Michael B. Ghadimi · 2 shared papers, 2024–2025 · strength 0.36
  3. Waldemar H. Uhl · 2 shared papers, 2024–2025 · strength 0.36
  4. Christoph Reißfelder · 2 shared papers, 2024–2025 · strength 0.36
  5. Jens Werner · 2 shared papers, 2024–2025 · strength 0.36
  6. Wolf Arif Mardin · 6 shared papers, 2011–2016 · strength 0.31
  7. Jörg Haier · 6 shared papers, 2011–2016 · strength 0.31
  8. Tengis Tschaidse · 1 shared paper, 2025 · strength 0.22
  9. Heinz Johannes Buhr · 1 shared paper, 2025 · strength 0.22
  10. Bernhard Willibald Renz · 1 shared paper, 2025 · strength 0.22
  11. Matthias Ilmer · 1 shared paper, 2025 · strength 0.22
  12. Jan Goesta D’Haese · 1 shared paper, 2025 · strength 0.22
  13. Sameer Abdallah Dhayat · 3 shared papers, 2011–2016 · strength 0.15
  14. Norbert J. Senninger · 3 shared papers, 2011–2016 · strength 0.15
  15. Marc Eric Martignoni · 1 shared paper, 2024 · strength 0.14
  16. Werner Hartwig · 1 shared paper, 2024 · strength 0.14
  17. Tim R. Glowka · 1 shared paper, 2024 · strength 0.14
  18. Maximilian Kießler · 1 shared paper, 2024 · strength 0.14
  19. Rüdiger Göß · 1 shared paper, 2024 · strength 0.14
  20. Ilaria Pergolini · 1 shared paper, 2024 · strength 0.14
  21. Karl J. Oldhafer · 1 shared paper, 2024 · strength 0.14
  22. Stephan Schorn · 1 shared paper, 2024 · strength 0.14
  23. Alexander Novotny · 1 shared paper, 2024 · strength 0.14
  24. Detlef Klaus Bartsch · 1 shared paper, 2024 · strength 0.14
  25. Carmen Mota Reyes · 1 shared paper, 2024 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.